VIELA BIO, INC. Marketable Securities (Current)
VIELA BIO, INC. had Marketable Securities (Current) of $237.62 million as of 2020-12-31, per its 10-K filed 2021-03-01.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Short-Term Investments
us-gaap:MarketableSecuritiesCurrent · last filed 2021-03-01
- 2020-12-31: Marketable Securities, Current $237.62M.
- 2020-09-30: Marketable Securities, Current $273.53M.
- 2020-06-30: Marketable Securities, Current $294.00M.
- 2020-03-31: Marketable Securities, Current $151.25M.
| Period end | Marketable Securities, Current |
|---|---|
| 2020-12-31 | $237.62M 10-K · filed 2021-03-01 |
| 2020-09-30 | $273.53M 10-Q · filed 2020-11-10 |
| 2020-06-30 | $294.00M 10-Q · filed 2020-08-12 |
| 2020-03-31 | $151.25M 10-Q · filed 2020-05-13 |
| 2019-12-31 | $113.94M 10-K · filed 2021-03-01 |
| 2019-09-30 | $42.49M 10-Q · filed 2019-11-14 |